What We Think and What We Know-Reference-Cited by-同舟云学术

What We Think and What We Know

Published:2002-10-01 Issue:10 Volume:25 Page:1876-1878
ISSN:0149-5992
Container-title:Diabetes Care
language:en
Short-container-title:

Author:

Buse John¹,Raftery Laura¹

Affiliation:

1. From the Division of Endocrinology, University of North Carolina (UNC) School of Medicine and UNC Health Care, Chapel Hill, North Carolina; and the Division of General Medicine and Clinical Epidemiology, University of North Carlolina (UNC) School of Medicine and UNC Health Care, Chapel Hill, North Carolina

Publisher

American Diabetes Association

Subject

Advanced and Specialized Nursing,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/care/article-pdf/25/10/1876/589688/dc1002001876.pdf

Reference8 articles.

1. Crespo CJ, Smit E, Snelling A, Sempos CT, Andersen RE: Hormone replacement therapy and its relationship to lipid and glucose metabolism in diabetic and nondiabetic postmenopausal women: results from the Third National Health and Nutrition Examination Survey (NHANES III). Diabetes Care 25:1675–1680, 2002

2. Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E: Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women: Heart and Estrogen/Progestin Replacement Study (HERS) Research Group. JAMA 280:605–613, 1998

3. Furberg CD, Vittinghoff E, Davidson M, Herrington DM, Simon JA, Wenger NK, Hulley S: Subgroup interactions in the Heart and Estrogen/Progestin Replacement Study: lessons learned. Circulation 105:917–922, 2002

4. Writing Group for the Women’s Health Initiative Investigators: Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women’s Health Initiative randomized controlled trial. JAMA 288:321–333, 2002

5. Ettinger B, Black DM, Mitlak BH, Knickerbocker RK, Nickelsen T, Genant HK, Christiansen C, Delmas PD, Zanchetta JR, Stakkestad J, Gluer CC, Krueger K, Cohen FJ, Eckert S, Ensrud KE, Avioli LV, Lips P, Cummings SR: Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial: Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators. JAMA 282:637–645, 1999

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prevention of cardiovascular outcomes in type 2 diabetes mellitus: trials on the horizon;Cardiology Clinics;2005-05

2. Prevention of Cardiovascular Outcomes in Type 2 Diabetes Mellitus: Trials on the Horizon;Endocrinology and Metabolism Clinics of North America;2005-03

3. Protective effects of 17β-estradiol and trivalent chromium on interleukin-6 secretion, oxidative stress, and adhesion of monocytes: Relevance to heart disease in postmenopausal women;Free Radical Biology and Medicine;2004-12

4. Progesterone, but not 17β-estradiol, increases TNF-α secretion in U937 monocytes;Cytokine;2004-05

5. Should Postprandial Glucose Be Routinely Measured and Treated to a Particular Target? No!;Diabetes Care;2003-05-01